Monte Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,268
Closed -$205K 86
2022
Q4
$205K Buy
+1,268
New +$194K 0.11% 83
2022
Q2
Sell
-1,268
Closed -$206K 75
2022
Q1
$206K Buy
+1,268
New +$184K 0.11% 80

Other funds holding ABBV

Monte Financial Group's ABBV Position: Q1 2023 in Review

Monte Financial Group sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 1,268 shares — an estimated $205K sold.

Monte Financial Group first reported a position in ABBV in Q1 2022 and held it in 2 quarters. The position peaked at $206K in Q1 2022. 3,138 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

  • Monte Financial Group reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
  • Monte Financial Group sold 1,268 AbbVie shares in Q1 2023, an estimated $205K.
  • Monte Financial Group first reported a position in AbbVie in Q1 2022 and held it in 2 quarters.
  • Monte Financial Group's AbbVie position peaked at $206K in Q1 2022.
  • 3,138 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Monte Financial Group's 13F filing for Q1 2023, filed 26 Apr 2023.